Randomised Trial of Tenectplase Versus Alteplase for Acute Stroke within 4.5h of Onset: The Second Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST-2)
Keith T. Muir(University of Glasgow), Gary A. Ford(Government of the United Kingdom), Ian Ford(University of Glasgow), Joanna M. Wardlaw(UK Dementia Research Institute), Alex McConnachie(University of Glasgow), Nicola Greenlaw(University of Glasgow), Grant Mair(University of Edinburgh), Nikola Sprigg(University of Nottingham), Christopher Price, Mary Joan MacLeod(University of Aberdeen), Sofia Dima(Royal Victoria Infirmary), Marius Venter(Charing Cross Hospital), Liqun Zhang(St George’s University Hospitals NHS Foundation Trust), Eoin O’Brien(Addenbrooke's Hospital), Ranjan Sanyal(Government of the United Kingdom), John Reid(Aberdeen Royal Infirmary), L. Sztriha(King's College Hospital NHS Foundation Trust), Syed Haider(Countess of Chester Hospital NHS Foundation Trust), William Whiteley(University of Edinburgh), James Kennedy(University of Oxford), Richard Perry(University College London), Lakshmanan Sekaran(Government of the United Kingdom), Annie Chakrabarti(Norfolk and Norwich University Hospital), Ahamad Hassan(Leeds General Infirmary), Richard Marigold(University of Southampton), Senthil Raghunathan(Nottingham University Hospitals NHS Trust), Don Sims(Queen Elizabeth Hospital), Mohit Bhandari(Watford General Hospital), Ivan Wiggam, Khalid Rashed(Taunton & Somerset NHS Foundation Trust), Chris Douglass(Government of the United Kingdom), ATTEST- Investigators
Cited by 8Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis